PMID: 25963003

Ooi CY, Castellani C, Keenan K, Avolio J, Volpi S, Boland M, Kovesi T, Bjornson C, Chilvers MA, Morgan L, van Wylick R, Kent S, Price A, Solomon M, Tam K, Taylor L, Malitt KA, Ratjen F, Durie PR, Gonska T
Inconclusive diagnosis of cystic fibrosis after newborn screening.
Pediatrics. 2015 Jun;135(6):e1377-85. doi: 10.1542/peds.2014-2081. Epub 2015 May 11., [PubMed]
Sentences
No. Mutations Sentence Comment
102 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:102:273
status: NEW
view ABCC7 p.Arg117His details
In contrast to previous reports, the vast majority of subjects with CFSPID carried 2 CFTR mutations.17-20 The majority of subjects were compound heterozygotes for 1 disease-causing mutation and 1 CFTR variant of variable or currently unknown consequence, with the F508del/ R117H-7T genotype being most common. Login to comment
103 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:48
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:308
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:473
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:840
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:918
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:996
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:1113
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:1157
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:1190
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:1202
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:1231
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:103:1299
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 25963003:103:624
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Ser1455*
X
ABCC7 p.Ser1455* 25963003:103:550
status: NEW
view ABCC7 p.Ser1455* details
ABCC7 p.Thr1299Ile
X
ABCC7 p.Thr1299Ile 25963003:103:767
status: NEW
view ABCC7 p.Thr1299Ile details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 25963003:103:728
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Gly576Ala
X
ABCC7 p.Gly576Ala 25963003:103:1223
status: NEW
view ABCC7 p.Gly576Ala details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25963003:103:496
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25963003:103:658
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Leu997Phe
X
ABCC7 p.Leu997Phe 25963003:103:1182
status: NEW
view ABCC7 p.Leu997Phe details
ABCC7 p.Arg170His
X
ABCC7 p.Arg170His 25963003:103:589
status: NEW
view ABCC7 p.Arg170His details
ABCC7 p.Leu967Ser
X
ABCC7 p.Leu967Ser 25963003:103:641
status: NEW
view ABCC7 p.Leu967Ser details
ABCC7 p.Tyr301Cys
X
ABCC7 p.Tyr301Cys 25963003:103:711
status: NEW
view ABCC7 p.Tyr301Cys details
ABCC7 p.Gln1476*
X
ABCC7 p.Gln1476* 25963003:103:693
status: NEW
view ABCC7 p.Gln1476* details
ABCC7 p.Gln1476*
X
ABCC7 p.Gln1476* 25963003:103:1277
status: NEW
view ABCC7 p.Gln1476* details
ABCC7 p.Glu527Gly
X
ABCC7 p.Glu527Gly 25963003:103:1136
status: NEW
view ABCC7 p.Glu527Gly details
ABCC7 p.Ser431Gly
X
ABCC7 p.Ser431Gly 25963003:103:821
status: NEW
view ABCC7 p.Ser431Gly details
ABCC7 p.Met1137Thr
X
ABCC7 p.Met1137Thr 25963003:103:675
status: NEW
view ABCC7 p.Met1137Thr details
ABCC7 p.Cys1410Thr
X
ABCC7 p.Cys1410Thr 25963003:103:1017
status: NEW
view ABCC7 p.Cys1410Thr details
ABCC7 p.Ile1328Thr
X
ABCC7 p.Ile1328Thr 25963003:103:606
status: NEW
view ABCC7 p.Ile1328Thr details
In combination with a disease-causing mutation, R117H-7T has been associated with diagnostic uncertainties in CF, TABLE 2 Genotypes of Subjects With CFSPID According to Initial Sweat Chloride Measurements Sweat Chloride ,30 mmol/L Sweat Chloride 30-59 mmol/L Allele 1 Allele 2 n Allele 1 Allele 2 n F508dela R117H (7T)b 9 F508dela R117Cd 2c F508dela 5Tb 2 F508dela L206Wd 2c F508dela D1152Hb 2 F508dela P67Ld 1c F508dela R117Hb 1 F508dela 5Tb 8 F508dela D1270Nb 1 F508dela R117H (7T)b 3 F508dela L997F 3 F508dela R117Hb 3 F508dela 1716G.A 1 F508dela S1455X 1c F508dela 621+3G.A 1 F508dela R170H 1 F508dela I1328T 1 F508dela I148T 1 F508dela L967S 1 F508dela L997F 1 F508dela M1137T 1 F508dela Q1476X 1 F508dela Y301C 1 F508dela S1235R 1 1717-1G.Aa D1152Hb 1 F508dela T1299I 1 2183AA.Ga 5Tb 1 2183AA.Ga R117Cd 1 2183AA.Ga S431G 1 2789+5G.Aa R117H (7T)b 1 3849+10kbC.Ta 3041-15T.G 1 3849+10kbC.Ta 3041-15T.G 1 621+1G.Ta R117H (7T)b 1 621+1G.Ta G1069Rb 1 711+1G.Ta D1152Hb 1 G542Xa L206Wd 1c G542Xa R117H (7T)b 1 G542Xa C1410T 1 G542Xa D1152Hb 1 G551Da 5Tb 1 G551Da D1152Hb 1 N1303Ka 5Tb 1 N1303Ka D1152Hb 1 R1162Xa R117H (7T)b 1c N1303Ka E527G 1 R553Xa 5Tb 1 R117H (5T)a 5Tb 1 R553Xa L997F 1 R117H (7T)b R117H (7T)b 1 R560Ta G576A 1 R117H (7T)b 3041_71G.C 1 W1282Xa 5Tb 2 R117Hb Q1476X 1 F508dela - 2 R117H (5T)a - 1 -, no mutation identified on the second allele. Login to comment
108 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:108:462
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 25963003:108:379
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 25963003:108:455
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 25963003:108:347
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 25963003:108:385
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Leu206Trp
X
ABCC7 p.Leu206Trp 25963003:108:423
status: NEW
view ABCC7 p.Leu206Trp details
ABCC7 p.Pro67Leu
X
ABCC7 p.Pro67Leu 25963003:108:307
status: NEW
view ABCC7 p.Pro67Leu details
ABCC7 p.Ser1455*
X
ABCC7 p.Ser1455* 25963003:108:266
status: NEW
view ABCC7 p.Ser1455* details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 25963003:108:225
status: NEW
view ABCC7 p.Arg117Cys details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 25963003:108:504
status: NEW
view ABCC7 p.Arg117Cys details
ABCC7 p.Arg117Cys
X
ABCC7 p.Arg117Cys 25963003:108:542
status: NEW
view ABCC7 p.Arg117Cys details
TABLE 3 Characteristics of Subjects With CFSPID Who Later Met Diagnostic Criteria of CF Subject Number Allele 1 Allele 2 Ethnicity NBS IRT, mg/L Initial Sweat Chloride, mmol/L Highest Sweat Chloride, mmol/L Country 1 F508del R117C White 105.8 36 61 Canada 2 F508del S1455X White 66.6 46 74 Canada 3 F508del P67L White 151.2 38 38 Canada 4 F508del L206W White 83.8 58 64 Canada 5 G542X L206W White 67 49 66 Canada 6 F508del L206W White 59.9 45 45 Canada 7 R1162X R117H-7T White 126 36 70 Italy 8 2183AA.G R117C White 129 32 32 Italy 9 F508del R117C White 80.4 48 56 Canada e OOI et al including in newborn-screened infants with equivocal CF diagnosis and in older individuals with single-organ manifestations of CF.17,18,20-22 As in the case of the 7 subjects who were initially classified as CFSPID but who were subsequently recognized to carry 2 disease-causing mutations on the basis of the CFTR2 project, the diagnostic consequences (benign versus disease-causing) of the CFTR mutations identified in all of the other subjects with CFSPID may not be apparent until later on, when new genetic information becomes available and classification of CFTR mutations currently considered to be of "unknown" consequences is updated. Login to comment
129 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 25963003:129:324
status: NEW
view ABCC7 p.Arg117His details
Current comparisons between CFSPID࢐CFSPID and CFSPID࢐CF do not account for these potential changes over time. There are similarities in the genotypes of subjects with CFSPID and symptomatic adults who present later in life with single-organ manifestations of CF, including but not exclusive to mutations such as R117H-7T.21,22 A long-term prospective study may shed more light into the proportion and characteristics of individuals with CFSPID who develop CF. Login to comment